tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Smart Value
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Jasper Therapeutics (JSPR)
NASDAQ:JSPR
US Market
JSPR
Jasper Therapeutics
Overview
Analyst Forecasts
AI Stock Analysis
Financials
Dividends
Technical Analysis
Options
Chart
Earnings
Ownership
Historical Prices
Stock Buybacks
Similar Stocks
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports

Jasper Therapeutics (JSPR) Stock News & Sentiment

Compare
896 Followers
Jasper Therapeutics Signs New Sales Agreement with Jefferies
Premium
Company Announcements
Jasper Therapeutics Signs New Sales Agreement with Jefferies
9d ago
8K
JSPR
Promising Innovations in Chronic Urticaria Treatment Drive Buy Rating for Jasper Therapeutics
Premium
Ratings
Promising Innovations in Chronic Urticaria Treatment Drive Buy Rating for Jasper Therapeutics
18d ago
JSPR
Positive Outlook for Jasper Therapeutics: Buy Rating Affirmed on Promising BEACON Study Data and Strategic Milestones
Premium
Ratings
Positive Outlook for Jasper Therapeutics: Buy Rating Affirmed on Promising BEACON Study Data and Strategic Milestones
26d ago
JSPR
Positive Outlook on Jasper Therapeutics: Sustained Efficacy and Safety of Briquilimab in CSU Treatment
Premium
Ratings
Positive Outlook on Jasper Therapeutics: Sustained Efficacy and Safety of Briquilimab in CSU Treatment
26d ago
JSPR
Promising Outlook for Jasper Therapeutics: Buy Rating Amidst Potential Upside and Strategic Developments
Premium
Ratings
Promising Outlook for Jasper Therapeutics: Buy Rating Amidst Potential Upside and Strategic Developments
26d ago
JSPR
Buy Recommendation for Jasper Therapeutics: Promising Developments in Briquilimab’s Phase 2b Program
Premium
Ratings
Buy Recommendation for Jasper Therapeutics: Promising Developments in Briquilimab’s Phase 2b Program
29d ago
JSPR
Promising Outlook for Jasper Therapeutics: Buy Rating Backed by Briquilimab’s Clinical Progress and Financial Stability
Premium
Ratings
Promising Outlook for Jasper Therapeutics: Buy Rating Backed by Briquilimab’s Clinical Progress and Financial Stability
29d ago
JSPR
More JSPR News >

JSPR News on the Web

Jasper Therapeutics Signs New Sales Agreement with Jefferies
TipRanks News
Neutral
RBC Capital Sticks to Their Buy Rating for Jasper Therapeutics (JSPR)
TipRanks News
Neutral
Jasper Therapeutics Presents Clinical and Preclinical Briquilimab Data at the American Academy of Allergy, Asthma, and Immunology Annual Meeting
Yahoo Finance
Neutral
Jasper Therapeutics Announces Late-Breaking Briquilimab Presentation at the American Academy of Dermatology Annual Meeting
Yahoo Finance
Neutral
Analysts Offer Insights on Healthcare Companies: Verve Therapeutics (VERV), Treace Medical Concepts (TMCI) and Jasper Therapeutics (JSPR)
TipRanks News
Neutral
Jasper Therapeutics to Present at Upcoming March Investor Conferences
Yahoo Finance
Neutral
Jasper Therapeutics to Present at the Oppenheimer Healthcare Life Sciences Conference
Yahoo Finance
Neutral
Promising Efficacy and Safety of Jasper Therapeutics’ Briquilimab Boosts Buy Rating
TipRanks News
Bullish

News Score - Last 7 Days

Neutral
JSPR
Sector Average
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
This Week59%
Sector Average60%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is JSPR’s Media Buzz Sentiment?
Currently, no data Available
What is JSPR’s weekly average amount of articles?
Currently, no data Available
What is JSPR’s News Sentiment?
59% of articles about JSPR were positive this week, compared to its sector average of 60%.
    Healthcare Stocks that are Trending in the News
    ALCAlcon
    SLNOSoleno Therapeutics
    DYAIDyadic International
    ASMBAssembly Biosciences
    CLGNCollplant Holdings
    Showing the stocks with the most bullish news sentiment over the past week

    Become an Expert with TipRanks Premium

    What am I Missing?
    Make informed decisions based on Top Analysts' activity
    Know what industry insiders are buying
    Get actionable alerts from top Wall Street Analysts
    Find out before anyone else which stock is going to shoot up
    Get powerful stock screeners & detailed portfolio analysis
    Subscribe NowSee Plans & Pricing